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Background: India has the second largest diabetic population (61 million) and tobacco users (275 million) in the
world. Data on smoking cessation among diabetic patients are limited in low and middle income countries. The
objective of the study was to document the effectiveness of diabetic specific smoking cessation counseling by a
non-doctor health professional in addition to a cessation advice to quit, delivered by doctors.
Methods: In our parallel-group randomized controlled trial, we selected 224 adult diabetes patients aged 18 years
or older who smoked in the last month, from two diabetes clinics in South India. Using a computer generated
random sequence with block size four; the patients were randomized equally into intervention-1 and intervention-2
groups. Patients in both groups were asked and advised to quit smoking by a doctor and distributed diabetes
specific education materials. The intervention-2 group received an additional diabetes specific 30 minutes
counseling session using the 5As (Ask, Advise, Assess, Assist and Arrange), and 5 Rs (Relevance, Risks, Rewards,
Roadblocks and Repetition) from a non-doctor health professional. Follow up data were available for 87.5% of
patients at six months. The Quit Tobacco International Project is supported by a grant from the Fogarty
International Centre of the US National Institutes of Health (RO1TW005969-01).
The primary outcomes were quit rate (seven day smoking abstinence) and harm reduction (reduction of the
number of cigarettes / bidis smoked per day > 50% of baseline use) at six months.
Results: In the intention to treat analysis, the odds for quitting was 8.4 [95% confidence interval (CI): 4.1-17.1] for
intervention-2 group compared to intervention-1 group. Even among high level smokers the odds of quitting was
similar. The odds of harm reduction was 1.9 (CI: 0.8-4.1) for intervention-2 group compared to intervention-1 group.
Conclusions: The value addition of culturally sensitive diabetic specific cessation counseling sessions delivered by
non-doctor health professional was an impressive and efficacious way of preventing smoking related diabetic
complications.
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India has the second largest population (1210 million) [1]
and number of people with diabetes (61 million) [2] and
tobacco users (275 million) [3] after China. Both diabetes
prevalence and tobacco use are increasing rapidly in India.
Although the proportion of smokers among all types of
tobacco users in India was only 40.5% in 2010, in contrast to
other countries, smoking was predicted to cause about one
million deaths [4]. Smoking is strongly linked to the risk of
diabetes morbidity as well as mortality [5-7]. The Inter-
national Diabetes Federation in 2003 [8] and the American
Diabetes Association in 2004 [9] have both strongly recom-
mended that people with diabetes not to smoke because of
increased risk of diabetes complications. The major compli-
cations are cardiovascular diseases [10], stroke [11], diabetic
retinopathy [12], and peripheral arterial disease [13].
Kerala, the Indian state most advanced in epidemiological
transition [14] and the state with the highest prevalence of
diabetes, was reported as the harbinger of what is going to
happen to the rest of India in the near future [15,16].
Current smoking prevalence of 27.9% among Kerala men
was higher than the 24.3% for the whole of India [3]. A pre-
vious Quit Tobacco International (QTI) study in Kerala
found that 59% of diabetes patients were tobacco users
(43.5% exclusive smokers) prior to diagnosis and more than
half of these users continued to use tobacco, many daily,
even after diagnosis. Notably, 52% had not been advised to
quit smoking by their doctors and did not associate smoking
with diabetes complications [17]. Given the prevalence of
smoking among diabetics, there was clearly a need for pro-
active cessation efforts. Results of a randomized controlled
trial from the US found that smoking cessation intervention
using motivational interviewing integrated into an estab-
lished diabetes self management training program curricu-
lum resulted in a trend towards greater abstinence at three
months of follow-up in those receiving the directed smoking
cessation intervention [18]. Data on smoking cessation
among diabetic patients are limited in low and middle in-
come countries. An Indonesian study of 71 diabetic patients
demonstrated the feasibility of disease-centred doctors’ mes-
sages about smoking cessation for these patients in a clinic
setting [19]. Considering the limited access to doctors in
India, particularly in rural areas, [20] there is a need to
utilize the services of non-doctor health professionals for
smoking cessation more frequently than doctors. The ob-
jective of the study was to document the effectiveness of dia-
betic specific cessation counseling by a non-doctor health
professional in addition to a diabetic specific cessation mes-
sage to quit, delivered by doctors.
Methods
Participants
All of the 2490 male diabetic patients (aged 18 years and
above) who attended two referral diabetes clinics locatedin peri-urban areas of two south Indian cities located in
Kerala state were screened for smoking through the use
of a brief instrument provided to patients at the clinic
registration counter from December 2008 to April 2011.
Among them 14.6% (n=363) were current smokers.
Being a pilot study we decided to include all the patients
who satisfied the inclusion criteria during the recruit-
ment period. Inclusion criteria for the study were: male
diabetes patients aged 18 years or above, literate, native
to the clinic catchment area, high probability that they
would be treated at the clinic for the next six months
and willingness to participate in the study. After exclud-
ing patients who did not meet inclusion criteria, or did
not agree to participate in the study (n=139) a total of
224 male diabetes patients (mean age 53 years) who
smoked in the previous month were selected for the
study. Female patients were excluded since the smoking
rate among females in Kerala was zero percent [3].
Ethical clearance for the study was given by the Sree
Chitra Tirunal Institute for Medical Sciences and
Technology, Trivandrum. Written consent to partici-
pate was obtained after patients were informed about
the purpose of the study. Patients were a mix of newly
diagnosed and long time patients (Figure 1).
Study procedure
The procedure followed was minimally invasive. A
screening instrument was kept at the hospital reception
where all the patients had to register after entering the
hospital. Smokers were identified by the counselor from
this screening tool which inquired the patient’s smoking
status. Patients attending the clinic routinely go to the
lab for a blood glucose examination and then have a
waiting period before lab results are ready and they can
be seen by the doctor. During this time, the counselor
met patients who had indicated a history of smoking on
the screening instrument. After being informed about
the study details written consent from the patients was
obtained. From those who gave consent, the counselor
collected baseline information using a pre tested struc-
tured interview schedule. Details about basic demo-
graphic information, smoking history, current smoking
patterns and presence of any other chronic diseases
(hypertension, cardiovascular disease, stroke, chronic ob-
structive pulmonary disease, and cancer) were collected.
Subsequently the counselor randomized the patients
equally into two groups; intervention–1 and interven-
tion–2 groups, with block size four. Sequentially, every
four patients enrolled were randomized into the two
intervention groups using a computer generated random
sequence to achieve a block size of four, to facilitate in-
terim analysis. Their medical records were then flagged
with different colored stickers by the counselor in order
to identify group assignment. After the interview, the
Assessed for eligibility (n=2490)
Excluded (n= 2266)
Not meeting inclusion criteria (n=2238)
Declined to participate (n=28)
Analysed (n=98)
Allocated to Intervention group-1 (n=112)
Received allocated intervention (n=112)
Allocated to Intervention group-2 (n=112)







Migration – 6, Inconvenience to attend on the 
follow-up day -5, Lost to follow up - 3
Drop out (n=14)
Migration – 4, Inconvenience to attend on the 
follow-up day -5, Lost to follow up -5  
Follow-Up at 6
months
Figure 1 Patient flow diagram.
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a standard diabetes specific tobacco cessation message.
The doctor also showed the patient visual images of com-
mon diabetes complications exacerbated by smoking. At
the end of consultation the doctor instructed the patient
to meet with the counselor. The counselor provided edu-
cational materials on tobacco and diabetes developed by
the QTI on the harm of tobacco for diabetes patients that
built on formative research and followed a question an-
swer format for all the patients [21] and gave follow up
dates for consultation to all patients.
Intervention–2 group patients received three diabetic
specific tobacco counseling sessions (at first contact, at
one month and at three months) lasting about 30 minutes
in each session following the 5 ‘A’s (Ask, Advise, Assess,
Assist and Arrange) and 5 ‘R’s (Relevance, Risks, Rewards,
Roadblocks and Repetition) [22]. In this session, after
going over the educational material, developed by the QTI
for smoking cessation, with the patient (to establishrelevance and support the doctor’s advice) the counselor
assessed each patient’s readiness to quit. If ready to quit,
the counselor assisted him by discussing practical quit
tips, how to get through an initial period of withdrawal,
and how to deal with common withdrawal symptoms, em-
phasizing that these only lasted for a few days. If not ready
to quit, the counselor briefly identified roadblocks and
challenges to quitting, and encouraged the patient to think
about quitting after reconsidering the risks of smoking for
developing diabetes complications and the benefits of
quitting as a means of preventing complications as a
prime motivator.
All patients were given smoking cessation advice on
each visit by the doctor for the next six months. Partici-
pants in intervention–2 group additionally received face
to face counseling sessions on each visit for the next six
months. Thus patients in the intervention group-2
received three counseling sessions: first at baseline, second
at month one and third at month three of follow-up.
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The doctors and diabetes educators selected to counsel
patients in the study sites were initially given training on
the harm of tobacco for diabetes patients including: 1) a re-
view of epidemiological data on smoking as a diabetes risk
factor, 2) complications strongly associated with smoking
among those afflicted with diabetics, and 3) the mechan-
isms through which smoking contributes to vascular con-
striction and obstructed blood flow. Educational materials
developed by the QTI for diabetes patients that explain
these facts in simple terms were provided to the counselor
to give to patients. Doctors and the counselors were also
trained in basic brief intervention cessations skills. Doctors
were instructed to ask all patients about their smoking sta-
tus and to strongly advise patients not to smoke using a
standardized diabetes specific cessation message linking
smoking to the complications of diabetes. Doctors were
provided a visual aid illustrating how tobacco narrows the
passage of blood in the vascular system and pictures illus-
trating diabetes complications at distal points of the vascu-
lar system such as eyes, feet, fingers, and penis. In sum, the
doctors were instructed to actively deliver two of the Five
As, Ask and Advise, using illness specific visual aids. The
counselors were given additional training in tobacco cessa-
tion counseling and instructed to actively conduct all of the
five ‘A’s with patients in intervention group–2 each time
they attended the clinic and 5 ‘R’s when necessary. The
counselors were instructed to document the details of ces-
sation offered to at least 15 patients using five ‘A’s and five
‘R’s. An examination was conducted by one of the authors
(MN) based on these 15 brief interventions to assess their
cessation skills. A certificate titled “basic tobacco cessation
competency” was issued on successful performance in the
examination by the University of Arizona.
Follow-up of patients
Follow up interviews were conducted with all study parti-
cipants in both groups at one month, three months and
six months. All the follow-up interviews were conducted
in person, although some of them were reminded by
phone calls to come for the follow-up visit. Patients were
asked about their smoking in the last seven days as well as
questions related to the number of cigarettes/bidis used in
an average day. We reminded all the patients in both the
groups by phone about the six month follow up in order
to get maximum response. All the diabetic patients fol-
lowed up at one, three and six months were seen by the
doctor and were advised to quit smoking.
Outcome measure
The primary outcome measure was a seven day smoking
abstinence (quit rate) measured by a question: “During
the past seven days, did you smoke even a puff?” Other
smoking outcomes gathered included patients’ reportson the number of cigarettes/bidis smoked on an average
day of use.
Statistical analysis
Statistical comparisons of means and proportions were
made using Student’s t-tests, Chi-square tests, Chi-square
tests for trend or Fisher’s exact test. The relative risk was
estimated by computing odds ratios (OR). Multivariable
models using multiple logistic regression analyses were
used to identify the correlates of quit rates. A complete
case analysis and intention to treat analysis were done. In
order to test our hypothesis that high level smokers are
more addicted to smoking and less likely to quit smoking
compared to their low level smoking counterparts, we did
a stratified analysis of baseline level smoking and quit rate
at six months. All the analyses were done using SPSS ver-
sion 17.0 and statistical significance was set at two tailed
p<0.05. The statistician was blinded to group assignment.
Results
We screened 2490 male diabetic patients. Among them
363 (14.6%) were current smokers. Of these 363 patients,
after excluding patients who were not willing to partici-
pate in the study (n=31), who were not the natives to the
clinic catchment area (n=89) and who could not come for
follow ups for the next six months (n=19), a total of 224
patients were included in the final study.
Average age of the study patients was 53 years (range
28–75). Under the age of 40 years there were 17 patients
(7.6%), confirming previous findings of the early onset of
diabetes in India [23]. Median duration of diabetes was six
years compared to the mean duration of eight years. Close
to three-fourths of the patients were subjectively assessed
by the counselors as belonging to the middle socioeco-
nomic status (SES) group, which was similar to the SES of
the general population in Kerala [24]. Baseline characteris-
tics in both the intervention groups were comparable
(Table 1).
The mean age of initiation of smoking was 21 years (SD
6.9, range: 8–56 years). Around 44% of patients initiated
smoking in their adolescent years (< 20 years). Twenty eight
patients (12.5%) were diagnosed in the last two years prior to
the study. Mean age of diagnosis of diabetes was 45.4 years
(SD: 10.1, range: 22–71 years). Thus on an average these
patients smoked 24 years before the diagnosis of diabetes.
In the first follow-up wave (month one) we were able
to contact 173 (77.2%) patients, in the second follow-up
(month three) 163 (72.8%) patients and in the third
follow-up (month six) 196 (87.5%) patients.
Quit rate and harm reduction
Smoking status of the patients at the six-month follow
up based on complete case analysis is given in Table 2
and that based on intention to treat analysis in Table 3.
Table 1 Baseline characteristics
Background characteristics Intervention group-1 Intervention group-2 P
valueN=112 N=112
Mean age (years) ± SD 54.2 ± 8.8 52.5 ± 9.9 0.193
Mean age of initiation of smoking (years) ± SD 20.9 ± 8.1 21.2 ± 5.6 0.723
Mean age at diagnosis of diabetes (years) ± SD 46.3 ± 9.2 44.5 ± 10.7 0.193
Mean duration of diabetes (years) ± SD 7.9 ± 6.1 8.0 ± 6.6 0.897
Mean number of sticks used per day at baseline ± SD 15.0 ± 14.6 14.1 ± 13.2 0.640
Currently Married (%) 98.2 94.6 0.140
Others (%) 01.8 05.4
< 10 years of schooling (%) 27.7 20.5 0.137
≥ 10 years of schooling (%) 72.3 79.5
Working (%) 61.6 66.1 0.289
Not working (%) 38.4 33.9
Low SES (%) 24.1 17.9
Middle SES (%) 72.3 75.9
Upper Middle SES (%) 03.6 06.3 0.376
Presence of any other chronic diseases (%) 39.3 38.4 0.500
SD = Standard Deviation. SES= Socioeconomic Status.
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196 patients (87.5%). The odds for quitting was 10 times
higher for intervention–2 group compared to interven-
tion–1 group in the complete case analysis and close to
nine times higher in the intention to treat analysis.
Harm reduction (defined as > 50% reduction in the
number of cigarettes/bidis used per day compared to
baseline use), which was significantly higher in the inter-
vention–2 group, was not found to be significant in the
intention to treat analysis. The mean number of cigar-
ettes/bidis smoked per day at month six was 4 (SD 8.2) in
the intervention–2 group, significantly lower (p < 0.001)
than that of 10 (SD 13.7) in the intervention–1 group in
complete case analysis.
The quit rate based on intention to treat analysis at
the one-month follow-up between the intervention–1
group (11.6%) and the intervention–2 group (19.6%) was
not statistically significant (p = 0.09). At three months
follow up the quit rate remained at almost the same level
in the intervention–1 group (10.7%), whereas in the inter-
vention–2 group the quit rate increased to 28.6% and the
difference was statistically significant ( p <0.001). At theTable 2 Smoking status at six months follow up using comple
Outcome Intervention group–1 (n=98) Intervention gro
n (%) n (%
Quit rate 14 (14.3) 58 (59
Harm reduction 25 (29.8) 20 (50
*Adjusted for age, education, occupation, presence of any other chronic disease, du
sticks per day. Quit Rate= Point prevalence abstinence of no smoking in the last se
more than 50% of baseline use. OR=Odds Ratio. CI = Confidence Interval.six-month follow-up the quit rate further increased to
51.8% in the intervention group–2. Among those who
came for all the three follow up visits in this group, statis-
tically significant (p=0.007) positive trend in quit rate was
seen with increase in the number of counseling sessions
attended.
Readiness to quit was assessed only for intervention
group-2 as part of the intervention strategy. Out of the
112 patients in the intervention – 2 groups 77 reported
that they were ready to quit at baseline. At six month
follow-up, 40 patients (51.9%) out of these 77, quit
smoking where as among the 35 patients who were not
ready to quit at baseline, 18 (51.4%) quit smoking at six
month follow-up.
Quit Rate at six months by baseline level of smoking
is given in Table 4. Although the quit rates among low
and high level smokers significantly increased in the
intervention-2 group, the increase in quit rate among
the medium level smokers did not achieve statistical sig-
nificance probably due to small sample size. However,
72% of the medium level smokers shifted to low level







.2) 8.7 (4.3-17.4) 10.7 (5.1-22.7) <0.001
.0) 2.3 (1.1-5.1) 2.6 (1.1-5.8) 0.025
ration of diabetes, volume of counseling sessions received and number of
ven days. Harm reduction=Reduction of smoking (number of sticks per day)
Table 3 Smoking status at six months follow up using intention to treat analysis





adjusted ORn (%) n (%)
Quit rate 14 (12.5) 58 (51.8) 7.5(3.8-14.7) 8.4 (4.1-17.1) <0.001
Harm reduction 25 (25.5) 20 (37.0) 1.71(0.84-3.5) 1.9 (0.8-4.1) 0.101
*Adjusted for age, education, occupation, presence of any other chronic disease, duration of diabetes, volume of counseling sessions received and number of
sticks per day. Quit Rate= Point prevalence abstinence of no smoking in the last seven days. Harm reduction=Reduction of smoking (number of sticks per day)
more than 50% of baseline use OR=Odds Ratio. CI = Confidence Interval.
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The study found that both the doctor’s message alone
and counseling lead many patients to quit or signifi-
cantly reduce their smoking habit. This was true of both
low level smokers at baseline and high level smokers.
Quit rates in the intervention–1 group were 12.5% at
month six compared to the baseline, indicating the im-
portance of routine smoking cessation advice by doctors
to all diabetes patients. Doctor’s cessation advice that is
disease specific is responded to better by patients than
general advise [21]. Our finding of a nearly nine times
higher quit rate (seven day abstinence from smoking) of
smoking in the intervention–2 group of diabetes patients
compared to the intervention–1 group indicates that
trained non-doctor health professional increases the
chances a patient will quit significantly.
The only prior study from a developing country on
cessation among diabetes patients from Indonesia
reported a quit rate of 30% in the group that received
doctor’s advice and 37% in the group that received doc-
tor’s advice and counseling. Although this difference in
quit rate was not statistically significant, the quit rate of
both groups’ was significantly higher at the six-month
follow-up compared to the base line. The quit rate of
52% in our intervention–2 group was much higher than
the 37% in Indonesia. This could be due to several fac-
tors, including the lower average number of cigarettes/
bidis smoked per day in Kerala compared to Indonesia,
the highly educated population in Kerala, better imple-
mentation of the national tobacco control program andTable 4 Quit Rate at six months by baseline level of




Quit rate P value
Intervention group-1 Intervention group-2
N (%) N (%)
Low 1 5/32 (15.6) 25/39 (64.1) < 0.001
Medium2 4/30 (13.3) 8/24 (33.3) 0.105
High3 5/50 (10.0) 25/49 (51.0) < 0.001
Total 14/112 (12.5) 58/112 (51.8) < 0.001
1Smoked 1–5 sticks (cigarettes / bidis) per day, 2 smoked 6–10 sticks per day,
3smoked more than 10 sticks per day.the repeated 30 minutes counseling sessions for quitting
each time the patient visited the clinic. High quit rates
of 50% at one year follow-up was reported by chronic
obstructive pulmonary disease (COPD) patients in a re-
cent study on smoking cessation buddies in COPD indi-
cating that high quit rates are possible in chronic disease
patients [25].
Generally, people including health professionals do not
associate smoking with diabetes. Awareness of the asso-
ciation between smoking and cancer, cardiovascular
diseases and respiratory diseases are generally higher
[26]. However, it was reported in a previous study from
Kerala that close to two thirds (64%) of diabetes patients
reported that smoking will not affect the disease and
only 10% reported that smoking causes a lot of aggrava-
tion of diabetes [27]. In our study both the doctor and
the counselor used visual aids and diabetes specific
smoking cessation materials developed by the QTI to
motivate patients to consider quitting to prevent compli-
cations from diabetes.
This study found a dose response relationship between
counseling and quit rate. The quit rate increased signifi-
cantly from the one-month follow-up to the third month
and again at the six-month follow-up. This demonstrates
the significance of repeat counseling at frequent inter-
vals for increasing quit rates and probably sustaining it.
It is important to treat smoking as a chronic disease
understanding the nature of addiction, possibility of
relapse and the need for continuum of care [28]. The
doctor employed the 2As (ask and advise) in their brief
intervention lasting three minutes. Non-doctor health
professionals who were trained as cessation counselors
employed all five ‘A’s and 5 ‘R’s adapted to the Indian
context during their 30 minute counseling sessions.
Their assisting patients to recognize the risks of smoking
and benefits of quitting, and to face physical, psycho-
logical and social roadblocks to quitting and plan quits
resulted in higher quit rates over time.
The Indian Institute of Diabetes in Kerala, one of our
study sites for this study, has taken note of the outcome
of this study and is currently planning to incorporate
smoking cessation counseling as a routine activity in
their diabetic clinics and advise the State Government to
follow this practice.
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Our study followed the patients only for six months, the
outcomes were self reported and we did not conduct bio-
chemical verification due to resource constraints. How-
ever, it has been reported by the Society for Research on
Nicotine and Tobacco subcommittee on biochemical veri-
fication that for population based trials with low demand
situation biochemical verification may not be necessary
[29]. The counselors who assessed the outcomes were not
blinded to the allocation groups while collecting follow up
data, although the statisticians who analyzed the data were
blinded. Since zero percent of women in Kerala smoked
they were excluded from this study [3]. With a large pro-
portion of diabetic smokers seemingly ineligible for the
study, another limitation is that the results may apply to
only specific smokers (male, literate, clinical care at the
same site over six months).
Conclusion
All doctors should routinely ask and advise diabetes
patients to quit smoking, including calling attention to
the complications that are more likely if they continue
to smoke. We have demonstrated that a brief interven-
tion by doctors is likely to result in a quit rate of about
10–13%. If this brief intervention is further supported by
counseling sessions by a trained non-doctor health pro-
fessional, the patients were able to reach a 52% quit rate
at the six-month follow-up. Even among the high level
smokers the quit rate at six months was 51%. And of
those who did not quit, at least 25% engaged in harm re-
duction by reducing their former smoking levels to more
than 50% of baseline. Counseling sessions using disease
specific diabetes messages and culturally sensitive use of
the five ‘A’s and five ‘R’s cessation protocol is an effica-
cious way of reducing smoking, an important risk factor
that significantly increases the chances of life threaten-
ing, debilitating and costly diabetes complications.
If this system of brief intervention by the doctors sup-
ported by a counseling session by a non-doctor health
professional can be incorporated in the national health
system, a substantial proportion of diabetes complica-
tions due to smoking can be prevented.
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